Royal Bank of Canada »

Aeglea Biotherapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-12-31 $94k 4.0k 23.37
2024-09-30 $113k 3.8k 29.91
2024-06-30 $77k 3.3k 23.65
2024-03-31 $2.0k 56 35.71
2023-09-30 $5.0k 437 11.44